CMS

Market Access

Hogan Lovells partner Alice Valder Curran returned to elucidate some of the finer points of the latest communication from CMS.

News

Medicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part.

News

CMS has extended the deadline for its Medicaid drug pricing pilot, GENEROUS, to "provide interested drug manufacturers more opportunity to join."

News

The US federal government has named the next 15 big-selling medicines that will be subject to Medicare pricing negotiations.

News

CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.

News

CMS unveils two more programmes in the Trump administration's efforts to cut drug prices, which have not been well received by the pharma industry.